Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals
Thursday, October 12, 2023Indivior PLC LSENasdaq INDV a leading addiction treatment company today announced that it has gained exclusive global rights to develop manufacture and commercialize Alar Pharmaceuticals Incs Alar portfolio of longacting injectable formulations that...
NurExone Secures Eureka Grant for Collaborative Partnership to Expand to Chronic Spinal Cord Injury Therapy
Thursday, October 12, 2023NurExone Biologic Inc TSXV NRX FSE J NRXV the Company or NurExone a biopharmaceutical company developing biologicallyguided exosome therapy ExoTherapy for patients with acute spinal cord injuries SCI is thrilled to announce that the Company has been...
Astria Therapeutics Announces Exclusive Worldwide License Agreement With Ichnos Sciences For OX40 Portfolio
Thursday, October 12, 2023Astria Therapeutics Inc NASDAQATXS a biopharmaceutical company focused on developing lifechanging therapies for allergic and immunological diseases today announced that it has entered into a worldwide exclusive license agreement with Ichnos Sciences...
Plus Therapeutics Completes Dosing in Cohort 4 of ReSPECT-LM Phase 1 Clinical Trial of Rhenium (¹⁸⁶Re) Obisbemeda in Leptomeningeal Metastases
Wednesday, October 11, 2023Plus Therapeutics Inc Nasdaq PSTV the Company a clinicalstage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers today announced it has completed dosing in Cohort of th...
Stem Pharm and Verge Genomics Form Collaboration Focused on Parkinson’s Disease
Wednesday, October 11, 2023Stem Pharm Inc a drug discovery platform company leveraging D neuroimmune organoids and Verge Genomics a biotechnology company transforming drug discovery using artificial intelligence AI and patient tissue data announced a collaboration to develop a...
Ventyx Biosciences Announces Positive Results From The Phase 2 Trial Of Vtx002 In Patients With Moderate-to-severely Active Ulcerative Colitis
Tuesday, October 10, 2023Ventyx Biosciences Inc Nasdaq VTYX Ventyx a clinicalstage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need today announced positive results fro...
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Tuesday, October 10, 2023Bristol Myers Squibb NYSE BMY and Mirati Therapeutics Inc NASDAQ MRTX today announced that they have entered into a definitive merger agreement under which Bristol Myers Squibb has agreed to acquire Mirati for per share in cash for a total equity va...
Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Bio
Saturday, October 07, 2023Talaris Therapeutics Inc Nasdaq TALS Talaris or the Company today announced that its Board of Directors has declared a special dividend in connection with the previously announced merger the Merger with Tourmaline Bio Inc Tourmaline pursuant to the A...
Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment
Friday, October 06, 2023Sanofi EURONEXT SAN and NASDAQ SNY and Teva Pharmaceuticals a US subsidiary of Teva Pharmaceutical Industries Ltd NYSE and TASE TEVA announce today a collaboration to codevelop and cocommercialize asset TEV
Starton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma
Friday, October 06, 2023Starton Therapeutics Inc Starton or the Company a clinicalstage biotechnology company focused on transforming standardofcare therapies with proprietary continuous delivery technology
